Infection and anorexia

Turkish Journal of Pediatrics

Volumn 48, Issue 4, 2006, Pages 279-287

  Kanra, Güler Y ^a   Özen, Hazan ^a   Kara, Ateş ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anorexia; Infection

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE RECEPTOR ANTAGONIST; DOPAMINE; HISTAMINE; IBUPROFEN; INDOMETACIN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERMEDIN; MONOCLONAL ANTIBODY; MURAMYL DIPEPTIDE; NEUROPEPTIDE Y; PARACETAMOL; PENTOXIFYLLINE; PROSTAGLANDIN E2; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANOREXIA; APPETITE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; INFECTION; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PERIPHERAL NERVOUS SYSTEM; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION;

ACUTE-PHASE REACTION; ANIMALS; ANOREXIA; APPETITE; APPETITE REGULATION; BACTERIAL INFECTIONS; BRAIN; CENTRAL NERVOUS SYSTEM; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXINS; HUMANS; INFECTION; INTERLEUKINS; LIPOPOLYSACCHARIDES; NEUROCHEMISTRY; NEUROPEPTIDE Y; PENTOXIFYLLINE; RATS; VIRUS DISEASES;

EID: 33846087343     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005; 5: 718-725.
2. Exton MS. Infection-induced anorexia: active host defence strategy. Appetite 1997; 29: 369-383.
3. Bowers TK, Eckert E. Leukopenia in anorexia nervosa: lack of increased risk of infections. Arch Intern Med 1978; 138: 1520-1523.
4. Marcus A. The immune system in eating disorders: an overview. Nutrition 1997; 13: 853-862.
5. Murray MJ, Murray AB. Anorexia of infection as a mechanism of host defense. Am J Clin Nutr 1979; 32: 593-596.
6. Wing EJ, Young JB. Acute starvation protects mice against Listeria monocytogenes. Infect Immun 1980; 28: 771-776.
7. Brady LS, Lynn AB, Herkenham M, et al. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 1994; 14: 4951-4964.
8. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988; 12: 123-127.
9. Matthys P, Billiau A. Cytokines and cachexia. Nutrition 1997; 13: 763-770.
10. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584-588.
11. Tracey KJ, Lowry SF, Cerami A. Cachectin: a hormone that triggers acute shock and chronic cachexia. J Infect Dis 1988; 157: 413-420.
12. Old LJ. Tumor necrosis factor (TNF). Science 1985; 230: 630-632.
13. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229: 869-871.
14. Tracey KJ, Hesse DG, Manogue KR, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662-664.
15. LeGrand EK. Why infection-induced anorexia? The case for enhanced apoptosis of infected cells. Med Hypotheses 2000; 54: 597-602.
16. Bazar KA, Yun AJ, Lee PY. "Starve a fever and feed a cold": feeding and anorexia may be adaptive behavioral modulators of autonomic and T helper balance. Med Hypotheses 2005; 64: 1080-1084.
17. Langhans W. Anorexia of infection: current prospects. Nutrition 2000; 16: 996-1005.
18. Murray J, Murray A, Murray N. Anorexia: sentinel of host defense? Perspect Biol Med 1978; 22: 134-142.
19. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci USA 1994; 91: 9995-9999.
20. Williams GT. Programmed cell death: a fundamental protective response to pathogens. Trends Microbiol 1994; 2: 463-464.
21. Legrand EK. Implications of early apoptosis of infected cells as an important host defense. Med Hypotheses 2000; 54: 597-602.
22. Giles KM, Hart SP, Haslett C, Rossi AG, Dransfield I. An appetite for apoptotic cells? Controversies and challenges. Br J Haematol 2000; 109: 1-12.
23. Langhans W. Bacterial products and the control of ingestive behavior: clinical implications. Nutrition 1996; 12: 303-315.
24. Schwartz GJ. Neural-immune gut-brain communication in the anorexia of disease. Nutrition 2002; 18: 528-533.
25. Kent S, Bret-Dibat JL, Kelley KW, Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev 1996; 20: 171-175.
26. Gayle D, Ilyin SE, Flynn MC, Plata-Salaman CR. Lipopolysaccharide (LPS)-, and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Res 1998; 795: 77-86.
27. Plata-Salaman CR, Borkoski JP. Centrally administered bacterial lipopolysaccharide depresses feeding in rats. Pharmacol Biochem Behav 1993; 46: 787-791.
28. Majde JA, Guha-Thakurta N, Chen Z, Bredow S, Krueger JM. Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: implications for the viral acute phase response. Arch Virol 1998; 143: 2371-2380.
29. Ankel H, Westra DF, Welling WS, Lebon P. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 1998; 251: 317-326.
30. Sachot C, Poole S, Luheshi GN. Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. J Physiol 2004; 561: 263-272.
31. Broberger C. Brain regulation of food intake and appetite: molecules and networks. J Int Med 2005; 258: 301-327.
32. Debonis D, Meguid MM, Lavianc, A, Yang ZJ, Gleason JR. Temporal changes in meal number and meal size relationship in response to rHu IL-1 alpha. Neuroreport 1995; 6: 752-756.
33. Bret-Dibat JL, Creminon C, Couraud JY, et al. Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1 beta. Brain Res Bull 1997; 42: 443-449.
34. Langhans W, Balkowski G, Savoldelli D. Further characterization of the feeding responses to interleukin-1 and tumor necrosis factor. In: Lehnert H, Murison R, Weiner H, Hellhammer D, Beyer J (eds). Endocrine and Nutritional Control of Basic Biological Functions. Seattle: Hogrefe & Huber; 1992: 135.
35. Malhotra R, Bird MI. L-selectin: a novel receptor for lipopolysaccharide and its potential role in bacterial sepsis. Bioessays 1997; 19: 919-923.
36. Rietschel ET, Schletter J, Weidemann B, et al. Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. Microb Drug Resist 1998; 4: 37-44.
37. Yang RB, Mark MR, Gray A, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-288.
38. Plata-Salaman CR. Anorexia during acute and chronic disease. Nutrition 1996; 2: 69-78.
39. Langhans W, Hrupka B. Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 1999; 33: 415-424.
40. Sonti G, Ilyin SE, Plata-Salaman CR. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 1996; 270: R1394-1402.
41. Spriggs MK. One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 1996; 14: 101-130.
42. Ploegh HL. Viral strategies of immune evasion. Science 1998; 280: 248-253.
43. Feingold KR, Soued M, Serio MK, et al. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 1989; 125: 267-274.
44. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA. Interleukin-1 induced anorexia in the rat. influence of Prostaglandins. J Clin Invest 1989; 84: 228-235.
45. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 329-337.
46. Miller AJ, Hopkins SJ, Luheshi GN. Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br J Pharmacol 1997; 20: 274-279.
47. Burgess W, Gheusi G, Yao JH, et al. Interleukin-1 beta-converting enzyme deficient mice resist central but not systemic endotoxin-induced anorexia. Am J Physiol 1998; 274: R1829-1833.
48. Arsenijevic D, Garcia I, Vesin C, et al. Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS. Eur Cytokine Netw 2000; 11: 662-668.
49. Langhans W, Savoldelli D, Weingarten S. Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiol Behav 1993; 53: 643-649.
50. Weingarten S, Savoldelli D, Langhans W. Enhancement or loss of the hypophagic eflect of interleukin-1 upon chronic administration. Physiol Behav 1992; 52: 831-837.
51. Finck BN, Johnson RW. Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1 beta in the rat. Brain Res 1997; 761: 333-337.
52. van Lettow M, van der Meer JW, West CE, van Crevel R Semba RD. Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi. J Clin Endocrinol Metab 2005; 90: 4771-4776.
53. Plata-Salaman CR. Cytokines and feeding. Int J Obes Relat Metab Disord 2001; 25(Suppl): S48-52.
54. Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG. Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Physiol 1997; 272: E908-917.
55. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters-a role for leptin in the anorexia of infection. J Clin Invest 1996; 97: 2152-2157.
56. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 85: 71-75.
57. Huang QH, Hruby VJ, Tatro JB. Role of central melanocortins in endotoxin induced anorexia. Am J Physiol 1999; 276: R864-871.
58. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 6: 1009-1012.
59. Kurosawa M, Uvnas-Moberg K, Miyasaka K, Lundeberg T. Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. J Auton Nerv Syst 1997; 62: 72-78.
60. Bret-Dibat JL, Bluthe RM, Kent S, Kelley KW, Dantzer R. Lipopolysaccharicle and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 1995; 9: 242-246.
61. Bluthe RM, Dantzer R, Kelley KW. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 1992; 573: 318-320.
62. Hrupka B, Porter M, Langhans W. Central and peripheral interactions of lipopolysaccharide and tumor necrosis factor. Appetite 1998; 31: 277 (Abstract).
63. Porter MH, Arnold M, Langhans W. TNF-alpha tolerance blocks LPS-induced hypophagia but LPS tolerance fails to prevent TNF-alpha-induced hypophagia. Am J Physiol 1998; 274: R741-745.
64. Ota K, Katafuchi T, Takaki A, Hori T. AV3V neurons that send axons to hypothalamic nuclei respond to the systemic injection of IL-1beta. Am J Physiol 1997; 272: R532-540.
65. Licinio J, Wong ML. Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 1997; 100: 2941-2947.
66. Cao C, Matsumura K, Yamagata K, Watanabe Y. induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res 1995; 697: 187-196.
67. Banks WA. Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J Neurovirol 1999; 5: 538-555.
68. de Vries HE, Blom-Roosemalen MC, van Oosten M, et al. The influence of cytokines on the integrity of the blood- brain barrier in vitro. J Neuroimmunol 1996; 64: 37-43.
69. Gayle D, Ilyin SE, Plata-Salaman CR. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res Bull 1997; 44: 311-317.
70. von Meyenburg C, Langhans W, Hrupka BJ. Evidence for a role of the 5-HT2C receptor in central lipopolysaccharide-, interleukin-1 beta-, and leptin-induced anorexia. Pharmacol Biochem Behav 2003; 74: 1025-1031.
71. Waldbillig RJ, Bartness TJ, Stanley BG. Increased food intake, body weight, and adiposity in rats after regional neurochemical depletion of serotonin. J Comp, Physiol Psychol 1981; 95: 391-405.
72. Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 1998; 4: 152-156.
73. Heisler LK, Cowley MA, Tecott LH, et al. Activation of central melanocortin pathways by fenfluramine. Science 2002; 297: 609-611.
74. Sonti G, Ilyin SE, Plata-Salaman CR. Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats. Peptides 1996; 7: 517-520.
75. Turrin NP, Flynn MC, Plata-Salaman CR. Neuropeptide Y counteracts interferon-alpha-induced anorexia. Neuroimmunomodulation 1999; 6: 361-366.
76. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Am J Clin Nutr 1997; 66: 683-706.
77. Plata-Salaman CR, French-Mullen JM. Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-lb. Physiol Behav 1992; 51: 277-279.
78. Plata-Salaman CR, Sonti G, Borkoski JP, Wilson CD, French-Mullen JM. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav 1996; 60: 867-875.
79. Johnson PM, Vogt SK, Burney MW, Muglia LJ. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am J Physiol Endocrinol Metab 2002; 282: E650-656.